GW Pharma

(Newser) - A company developing a marijuana-based mouth spray for cancer pain is hoping for FDA approval by next year. British firm GW Pharma is already carrying out advanced clinical trials for Sativex, the first pharmaceutical developed from raw marijuana, reports AP . Sativex contains marijuana components delta 9-THC and cannabidiol, and has...